Abstract:Ventricular septal defects (VSDs) are the most common type of congenital head diseases (CHDs). To date, the genetic causes for sporadic VSDs remain largely unknown. GATA transcription factor 4 (GATA4) is a zinc-finger transcription factor that is expressed in developing heart and adult cardiomyocytes. Mutations in the coding region of the GATA4 gene have been identified in CHD patients, including VSD. As the GATA4 factor is a dosage-sensitive regulator, we hypothesized that the promoter region variants of the GATA4 gene may be genetic causes of VSD. In this study, we analyzed the promoter region of the GATA4 gene by bidirectional sequencing in 172 VSD patients and 171 healthy controls. The results showed that 5 heterozygous sequence variants (NG_008177:g.4071T>C, NG_008177:g.4148C>A, NG_008177:g.4566C>T, NG_008177:g.4653G>T, and NG_008177:g.4690G>deletion) within the promoter region of the GATA gene were identified in 5 VSD patients, but in none of controls. One heterozygous sequence variant (g.4762C>A) was found only in one control, which may have no functional significance. A functional analysis revealed that the transcriptional activity of variant NG_008177:g.4566C>T was reduced significantly, whereas the transcriptional activities of the variants (NG_008177:g.4071T>C, NG_008177:g.4148C>A, NG_008177:g.4653G>T, and NG008177:g.4690G>deletion) were increased significantly compared with the wild-type GATA4 gene promoter. As GATA4 is a dosage-sensitive regulator during development, our data suggest that these sequence variants within the promoter region of the GATA4 gene may contribute to the VSD etiology by altering its gene expression. Additional studies in experimental animals will deepen our understanding of the genetic basis of VSD and shed light on designing novel molecular therapies for adult VSD patients carrying these variants. (Translational Research 2012;159:376-382)

Human Genetics of Ventricular Septal Defect

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

Novel NKX2-5 Mutations Identified in Patients with Congenital Ventricular Septal Defects

A Novel NKX2-5 Mutation in Familial Ventricular Septal Defect.

[A Novel GATA4 Mutation Leading to Congenital Ventricular Septal Defect].

Familial Ventricular Aneurysms and Septal Defects Map to Chromosome 10P15

A Novel Nkx2.6 Mutation Associated with Congenital Ventricular Septal Defect

Genome-wide Copy Number Variant Analysis for Congenital Ventricular Septal Defects in Chinese Han Population

Novel GATA6 Mutations Associated with Congenital Ventricular Septal Defect or Tetralogy of Fallot.

A Novel GATA4 Loss-of-Function Mutation Associated with Congenital Ventricular Septal Defect

Human Genetics of Defects of Situs

Genetic Insights into Congenital Cardiac Septal Defects—A Narrative Review

Placental epigenetics for evaluation of fetal congenital heart defects: Ventricular septal defect (VSD)

Molecular genetics of congenital heart disease

Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects.

Prenatal genetic diagnosis associated with fetal ventricular septal defect: an assessment based on chromosomal microarray analysis and exome sequencing

Risk factor analysis for adverse prognosis of the fetal ventricular septal defect (VSD)

Novel NKX2-5 Mutations in Patients With Familial Atrial Septal Defects

Research into Gene Mutation in Development of Congenital Atrial Septal Defect and Ventricular Septal Defect

Rare copy number variation analysis identifies disease-related variants in atrioventricular septal defect patients

[Novel GATA4 Mutations Identified in Patients with Congenital Atrial Septal Defects].